![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, January 12, 2022 10:49:26 AM
Could the current legal battle between Relief and Neuro be tolerable for the companies for the time being because it allows insiders to buy more at a cheap price before good news is announced. The problems could be easily and quickly resolved. That, for instance, could be done overnight by a buyout.
We have not here heard much about the Owens and Minor buyout of Relief Therapeutics formerly (I am not sure of the current status) wholly owned subsidiary Applied Pharma Research (APR ) which has been developing Relief's Sentinox Nasal Spray. Could that be the first step towards a Relieftherapeutics (and maybe also Neuro) buyout?
Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM
Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM
Kona Gold Beverage Significantly Reduces Debt from Multiple Holders • KGKG • Jul 31, 2024 9:00 AM
Avant Technologies Opens Equity Line with GHS Investments as Company Explores Expansion into Additional Technologies • AVAI • Jul 30, 2024 8:00 AM
ELEMENT79 GOLD CORP PROVIDES UPDATE ON CHACHAS COMMUNITY CHARTER AND REVENUE GENERATION, M&A ACTIVITIES • ELMGF • Jul 30, 2024 8:00 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM